浙江震元(000705.SZ):擬定增募資不超6.01億元 用於震元堂母嬰護理中心拓展項目等
格隆匯8月9日丨浙江震元(000705.SZ)公佈非公開發行A股股票預案,此次非公開發行擬發行股票數量按照此次非公開發行募集資金總額除以發行價格計算得出,且不超過此次發行前公司總股本的30%,即不超過100,236,985股(含本數)。
公司此次非公開發行股票的定價基準日為發行期首日,發行價格不低於定價基準日前二十個交易日公司股票交易均價的80%。發行對象為包括公司控股股東震元健康集團在內的不超過35名特定投資者。
此次非公開發行股票募集資金總額不超過6.014億元(含本數),扣除發行費用後的募集資金淨額,擬投資2.229億元用於震元堂母嬰護理中心拓展項目、擬2.035億元用於凍乾製劑擴產及高端注射製劑技術平台建設項目、擬1.75萬萬元用於智慧醫藥倉儲物流二期項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.